» Articles » PMID: 20425526

Heparin and Aspirin Versus Aspirin Alone for Prevention of Recurrent Pregnancy Loss

Overview
Publisher Current Science
Specialty Rheumatology
Date 2010 Apr 29
PMID 20425526
Citations 2
Authors
Affiliations
Soon will be listed here.
Citing Articles

High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant.

Gebhart J, Posch F, Koder S, Quehenberger P, Perkmann T, Kuessel L Blood Adv. 2019; 3(5):769-776.

PMID: 30837214 PMC: 6418496. DOI: 10.1182/bloodadvances.2018026948.


Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.

Bala M, Paszek E, Lesniak W, Wloch-Kopec D, Jasinska K, Undas A Cochrane Database Syst Rev. 2018; 7:CD012534.

PMID: 30004572 PMC: 6513409. DOI: 10.1002/14651858.CD012534.pub2.

References
1.
FRANKLIN R, Kutteh W . Antiphospholipid antibodies (APA) and recurrent pregnancy loss: treating a unique APA positive population. Hum Reprod. 2002; 17(11):2981-5. DOI: 10.1093/humrep/17.11.2981. View

2.
Kutteh W . Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996; 174(5):1584-9. DOI: 10.1016/s0002-9378(96)70610-5. View

3.
Rai R, Cohen H, Dave M, Regan L . Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ. 1997; 314(7076):253-7. PMC: 2125731. DOI: 10.1136/bmj.314.7076.253. View

4.
Farquharson R, Quenby S, Greaves M . Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment. Obstet Gynecol. 2002; 100(3):408-13. DOI: 10.1016/s0029-7844(02)02165-8. View

5.
Pattison N, Chamley L, Birdsall M, Zanderigo A, LIDDELL H, McDougall J . Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial. Am J Obstet Gynecol. 2000; 183(4):1008-12. DOI: 10.1067/mob.2000.106754. View